Moreover, the increase in TNFRSF11B expression has been demonstrated to enhance the movement and infiltration of glioma cells, while also providing protection against chemotherapy medications in laboratory settings [49]. The gene discussed is TNFRSF11B; the disease is central nervous system cancer.